| | |
| Clinical data | |
|---|---|
| Other names | 1-Propanoyl-lysergic acid methylisopropylamide; 1-Propanoyl-MIPLA; N,6-Dimethyl-1-propanoyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H29N3O2 |
| Molar mass | 379.504 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1P-MIPLA, also known as 1-propanoyl-lysergic acid methylisopropylamide (1-propanoyl-MIPLA), is a designer drug and presumed serotonergic psychedelic of the lysergamide family related to lysergic acid diethylamide (LSD). [1] [2] [3] It is the 1-propanoyl derivative of MIPLA and may act as a prodrug of MIPLA. [1] [2] [3] 1P-MIPLA has been discussed on specialized online forums since 2018. [1] In addition, a designer drug product labeled "1P-MIPLA" but actually containing MIPLA was encountered in Austria in 2019. [1]